Botanix Pharmaceuticals Limited
BXPHF · OTC
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Market Cap | $812,944 | $450,859 | $103,904 | $53,138 |
| - Cash | $64,967 | $79,308 | $10,250 | $7,286 |
| + Debt | $32,106 | $0 | $122 | $122 |
| Enterprise Value | $780,083 | $371,551 | $93,776 | $45,975 |
| Revenue | $5,757 | $2,069 | $3,772 | $2,755 |
| % Growth | 178.2% | -45.1% | 36.9% | – |
| Gross Profit | $2,319 | -$1,583 | -$3,046 | -$7,538 |
| % Margin | 40.3% | -76.5% | -80.7% | -273.6% |
| EBITDA | -$82,162 | -$13,786 | -$8,962 | -$12,990 |
| % Margin | -1,427.1% | -666.2% | -237.6% | -471.5% |
| Net Income | -$86,396 | -$13,870 | -$9,154 | -$13,171 |
| % Margin | -1,500.6% | -670.2% | -242.7% | -478.1% |
| EPS Diluted | -0.047 | -0.009 | -0.008 | -0.014 |
| % Growth | -408.7% | -16.5% | 41.5% | – |
| Operating Cash Flow | -$78,585 | -$8,127 | -$12,074 | -$11,184 |
| Capital Expenditures | -$1,050 | -$17,999 | -$7,054 | -$2,922 |
| Free Cash Flow | -$79,635 | -$26,127 | -$19,128 | -$14,106 |